On our screens:Stocks with no debtCheap stocks by free cash flow yieldQuality compoundersQuality at a reasonable price
Is the price fair?
What ADUS's price assumes
Addus HomeCare Corporation trades at 22.0× earnings against 19.6× for the median Medical Care Facilities name, more expensive than its own group.
22.0
Trailing P/E · Medical Care Facilities median 19.6 · 1.13× the median: the market pays up for this one
- Price / sales
- 1.20
Price / sales · as of 2026-Q1
- Free cash flow yield
- 7.6%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +0.08%
Growth the price implies · The price pays for +0.08% free cash flow growth a year for a decade; the business has delivered +7.7% a year over the last three.
Details›
- Price / book2026-Q1
- 1.55
- Healthcare median P/E362 names
- 29.9
- Medical Care Facilities median P/E29 names
- 19.6
- Free cash flow, trailing twelve months
- $137M
- Market capitalisation
- $1.81B
- 3-year revenue growth
- +14%
- 3-year free cash flow growth
- +7.7%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $149.00 |
| Its own P/E history, median | $179.27 |
| Its own P/E history, upper quartile | $243.77 |
| 52-week range | $88.49 – $122.75 |
| Today | $119.41 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.